BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Ocular Therapeutix Announces Executive Transition Plans

  June 23, 2017

   · 

  6 min read
• Drug Development

  Smithers Avanza Poster Confirms The Guinea Pig Model For Preclinical Vaccine Safety Testing

  June 23, 2017

   · 

  1 min read
• Lone Star Bio

  Advanced Pharmaceuticals, D/B/A Avella Of Houston Issues Voluntary Nationwide Recall Of Specific Lots Of Potassium Phosphate And Succinylcholine Repacked And/Or Compounded At Its Houston Location As A Result Of Hospira’s June 15, 2017 Recall Of Such Produ

  June 23, 2017

   · 

  3 min read
• EUSA Pharma Receive Positive Opinion From The CHMP For Tivozanib For The First-Line Treatment Of Advanced Renal Cell Carcinoma In The European Union

  June 23, 2017

   · 

  9 min read
• Drug Development

  BIO2017 CARsgen Therapeutics Presented At The 2017 BIO International Convention

  June 23, 2017

   · 

  2 min read
• Biotech Bay

  European CHMP Adopts Positive Opinion For Gilead’s Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir) For The Treatment Of All Chronic Hepatitis C Genotypes

  June 23, 2017

   · 

  4 min read
• Genetown

  ArQule Presents Preclinical Data For BTK Inhibitor, ARQ 531, At The 22nd Annual Congress Of European Hematology Association

  June 23, 2017

   · 

  5 min read
• Drug Development

  bluebird bio Presents New Data From HGB-205 Study Of LentiGlobin Drug Product In Patients With Transfusion-Dependent ?-Thalassemia (TDT) And Severe Sickle Cell Disease (SCD) At European Hematology Association Annual Meeting

  June 23, 2017

   · 

  10 min read
• Drug Development

  Takeda Presents Data From Phase I/II Studies For NINLARO (Ixazomib) In Newly Diagnosed Multiple Myeloma Patients And In The Maintenance Setting

  June 23, 2017

   · 

  14 min read
• Acceleron Pharma Provides Updated Results From Ongoing Phase II Study Of Luspatercept In Myelodysplastic Syndromes At The 22nd Congress Of The European Hematology Association

  June 23, 2017

   · 

  8 min read